Pracipio Ltd
- Biotech or pharma, therapeutic R&D
- CMO, CRO
- Financial, legal, consulting
- Investor (buy-side or sell-side research)
Pracipio supports Biotechs and Integrated Pharma with strong insights solutions, capability and capacity support across a wide range of needs, both on the buy and the sell-side. At the core of Pracipio is a group of more than 800 associate subject matter exports and consultants to ensure a bespoke solution for your challenges. Pracipio also represents a handful of specific clients during Bio International for partnering, notably Abbatialabs (novel 'sprinkles' based oral solids solutions, Galenicap (highly innovative 505b2 assets, including Phase III, and notably Eumcure, targeting chronic pouchitis), Carocell Bio (a novel topical anti-inflammatory peptide targeting p38a in Phase 0) and others, including innovative CDMO service providers such as HealSun..
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}